Barclays’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Buy |
139,900
+71,539
| +105% | +$812K | ﹤0.01% | 2385 |
|
|
2025
Q1 | $454K | Sell |
68,361
-11,751
| -15% | -$78K | ﹤0.01% | 2901 |
|
|
2024
Q4 | $884K | Buy |
80,112
+372
| +0.5% | +$4.11K | ﹤0.01% | 2705 |
|
|
2024
Q3 | $980K | Buy |
79,740
+47,239
| +145% | +$581K | ﹤0.01% | 2631 |
|
|
2024
Q2 | $439K | Buy |
32,501
+11,877
| +58% | +$160K | ﹤0.01% | 2603 |
|
|
2024
Q1 | $278K | Sell |
20,624
-18,647
| -47% | -$251K | ﹤0.01% | 3163 |
|
|
2023
Q4 | $206K | Buy |
39,271
+30,831
| +365% | +$162K | ﹤0.01% | 3495 |
|
|
2023
Q3 | $33K | Sell |
8,440
-6,389
| -43% | -$25K | ﹤0.01% | 3754 |
|
|
2023
Q2 | $157K | Sell |
14,829
-8,031
| -35% | -$85K | ﹤0.01% | 3204 |
|
|
2023
Q1 | $190K | Buy |
22,860
+4,417
| +24% | +$36.7K | ﹤0.01% | 3177 |
|
|
2022
Q4 | $170K | Buy |
18,443
+7,880
| +75% | +$72.6K | ﹤0.01% | 3185 |
|
|
2022
Q3 | $135K | Buy |
10,563
+642
| +6% | +$8.21K | ﹤0.01% | 3277 |
|
|
2022
Q2 | $131K | Buy |
9,921
+5,236
| +112% | +$69.1K | ﹤0.01% | 3356 |
|
|
2022
Q1 | $98K | Sell |
4,685
-18,484
| -80% | -$387K | ﹤0.01% | 3677 |
|
|
2021
Q4 | $556K | Buy |
23,169
+14,000
| +153% | +$336K | ﹤0.01% | 2486 |
|
|
2021
Q3 | $233K | Sell |
9,169
-1,844
| -17% | -$46.9K | ﹤0.01% | 2909 |
|
|
2021
Q2 | $370K | Sell |
11,013
-6,634
| -38% | -$223K | ﹤0.01% | 2622 |
|
|
2021
Q1 | $686K | Buy |
17,647
+12,514
| +244% | +$486K | ﹤0.01% | 2494 |
|
|
2020
Q4 | $318K | Sell |
5,133
-1,682
| -25% | -$104K | ﹤0.01% | 2521 |
|
|
2020
Q3 | $229K | Sell |
6,815
-3,166
| -32% | -$106K | ﹤0.01% | 2670 |
|
|
2020
Q2 | $239K | Buy |
9,981
+3,783
| +61% | +$90.6K | ﹤0.01% | 2718 |
|
|
2020
Q1 | $142K | Sell |
6,198
-3,638
| -37% | -$83.3K | ﹤0.01% | 2680 |
|
|
2019
Q4 | $278K | Buy |
9,836
+3,835
| +64% | +$108K | ﹤0.01% | 3012 |
|
|
2019
Q3 | $129K | Buy |
6,001
+5,087
| +557% | +$109K | ﹤0.01% | 3273 |
|
|
2019
Q2 | $27K | Buy |
+914
| New | +$27K | ﹤0.01% | 3934 |
|